Clariant has announced the completion of the sale of its Healthcare Packaging business to a newly-formed investment of Arsenal Capital Partners, the signing of which was completed on July 22nd, 2019.
The sale was closed on October 31st.
Hariolf Kottmann, Executive Chairman of Clariant, said: “The divestment of the Heathcare Packaging business is the first step of our announced strategy to become a more focused and innovative specialty chemical company.”
The total consideration of the sale amounts to approximately CHF 308 million, which is equivalent to 13.2 times adjusted FY 2018 EBITDA.